NCT06828055Phase 2Completed

VK2735 for Weight Management Phase 2 (Venture Oral Dosing)

Study sponsor: Viking Therapeutics, Inc. · VKTX

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2025-06-24Actual

Enrollment · participants280Actual

Source updated2025-10-06Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2025-10-06 · 4 fields changed

Participant count type changed

− Before

~~Estimated~~

+ After

Actual

Completion date type changed

− Before

~~Estimated~~

+ After

Actual

Primary completion date changed

− Before

~~Aug 2025~~

+ After

24 Jun 2025

Recruitment status changed

− Before

~~Recruiting~~

+ After

Completed

Check registry source